Acute Leukemias II

Prognostic Factors and Treatment Strategies

Acute Leukemias II

Prognostic Factors and Treatment Strategies

106,99 €*

in Vorbereitung

Falls Sie eine Lieferung außerhalb DE, AT oder CH wünschen, nutzen Sie bitte unser Kontaktformular für eine Anfrage.

Acute leukemia a quite homogenous disease failed to break through the sound barriere of when untreated reveals a substantial hetero unsatisfactory cure rates even in special sub geneity in its response to therapy. While cure groups. While new protocols including more is achieved in a certain proportion of pa effective supportive care show some increase tients other cases prove to be highly resis in the initial response rates and certain im tant. The curability is superior in acute provements in the long-term results, no ben lymphoblastic (ALL) than in acute myeloid eficial effect on the relapse rate during the (AML) leukemia and - within both type- first 1 Y2 years emerged from any of these higher in children as compared to adults. regimens. Thus, high chances for cure are The two age groups and cell types can be presently restricted to children with ALL further subdivided into prognostic groups and to lesser proportions children with by special diagnostic features. Thus, in AML and adults with ALL and AML.

Leukemia Cell Biology and Basic Science
Acute Myelogenous Leukemia in Children
Acute Myelogenous Leukemia in Adults
Acute Lymphoblastic Leukemia in Adults
Acute Lymphoblastic Leukemia in Children
Supportive Care in Acute Leukemias
Treatment of Relapse and Pharmacokinetics
Bone Marrow Transplantation
Hematopoietic Growth Factors.
ISBN 9783540509844
Artikelnummer 9783540509844
Medientyp Buch
Copyrightjahr 1990
Verlag Springer, Berlin
Umfang 776 Seiten
Abbildungen XXI, 776 p. 45 illus.
Sprache Englisch